Overview

An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis

Status:
Terminated

Trial end date:
2021-09-17

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and effectiveness of BMS-986165 compared with placebo with regard to measures of kidney function in participants with lupus nephritis (LN).

Phase:

Phase 2

Details

Lead Sponsor:

Bristol-Myers Squibb

Treatments:

BMS-986165
Mycophenolic Acid